69 related articles for article (PubMed ID: 8486596)
1. Molindone and weight loss.
Heikkinen H; Outakoski J; Meriläinen V; Tuomi A; Huttunen MO
J Clin Psychiatry; 1993 Apr; 54(4):160-1. PubMed ID: 8486596
[No Abstract] [Full Text] [Related]
2. Review of clinical and laboratory experiences with molindone hydrochloride.
Claghorn JL
J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):30-3. PubMed ID: 3894340
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine-molindone interaction.
Malek-Ahmadi P; Allen SA
J Clin Psychiatry; 1995 Feb; 56(2):82-3. PubMed ID: 7852260
[No Abstract] [Full Text] [Related]
4. Weight reduction in schizophrenics by molindone.
Gardos G; Cole JO
Am J Psychiatry; 1977 Mar; 134(3):302-4. PubMed ID: 842709
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with molindone hydrochloride in geriatric patients.
Peper M
J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):26-9. PubMed ID: 3894339
[TBL] [Abstract][Full Text] [Related]
6. Molindone--a new antipsychotic drug.
Med Lett Drugs Ther; 1975 Jul; 17(14):59. PubMed ID: 237228
[No Abstract] [Full Text] [Related]
7. Long-term study of molindone hydrochloride in chronic schizophrenics.
Kellner R; Rada RT; Egelman A; Macaluso B
Curr Ther Res Clin Exp; 1976 Nov; 20(5):686-94. PubMed ID: 825355
[No Abstract] [Full Text] [Related]
8. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
[No Abstract] [Full Text] [Related]
9. Galactorrhea associated with molindone.
Wesp CE; Annitto W; Feinsod R
Am J Psychiatry; 1979 Jul; 136(7):975. PubMed ID: 572143
[No Abstract] [Full Text] [Related]
10. Potential lower efficacy of molindone among first-generation antipsychotics.
Waugaman RM
Am J Psychiatry; 2009 Apr; 166(4):491; author reply 492-3. PubMed ID: 19339370
[No Abstract] [Full Text] [Related]
11. Effect of molindone on weight change in hospitalized schizophrenic patients.
Parent MM; Roy S; Sramek J; Lawson W; Herrera J
Drug Intell Clin Pharm; 1986 Nov; 20(11):873-5. PubMed ID: 3780420
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of molindone in schizophrenics.
Abuzzahab FS
J Clin Pharmacol; 1973 Oct; 13(10):422-6. PubMed ID: 4583573
[No Abstract] [Full Text] [Related]
13. Treatment of acute schizophrenia with molindone.
Abuzzahab FS
J Clin Pharmacol; 1973; 13(5):226-33. PubMed ID: 4575563
[No Abstract] [Full Text] [Related]
14. Combined use of molindone and guanethidine in patients with schizophrenia and hypertension.
Simpson LL
Am J Psychiatry; 1979 Nov; 136(11):1410-4. PubMed ID: 495792
[TBL] [Abstract][Full Text] [Related]
15. Molindone and hepatotoxicity.
Bhatia SC; Banta LE; Ehrlich DW
Drug Intell Clin Pharm; 1985 Oct; 19(10):744-6. PubMed ID: 4053979
[TBL] [Abstract][Full Text] [Related]
16. Dystonic reaction during maintenance antipsychotic therapy.
Gardos G
Am J Psychiatry; 1981 Jan; 138(1):114-5. PubMed ID: 7446763
[No Abstract] [Full Text] [Related]
17. [Longitudinal comparative study of risperidone vs classical neuroleptics in the treatment of schizophrenia: 24 months of observation].
Bouchard RH
Encephale; 2002; 28 Spec No 2 Pt 2():S31-2. PubMed ID: 12587355
[No Abstract] [Full Text] [Related]
18. Neuroleptic-induced priapism.
Gomez EA
Tex Med; 1985 Sep; 81(9):47-8. PubMed ID: 4049294
[No Abstract] [Full Text] [Related]
19. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of molindone in treatment-refractory agitated schizophrenia: three case reports.
Ciranni M; Lindenmayer JP; Gold J
J Clin Psychiatry; 2008 Jun; 69(6):1018-9. PubMed ID: 18684000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
